Amalgamated Bank Dexcom Inc Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Dexcom Inc stock. As of the latest transaction made, Amalgamated Bank holds 84,114 shares of DXCM stock, worth $6.67 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
84,114
Previous 84,778 0.78%
Holding current value
$6.67 Million
Previous $9.61 Million 41.33%
% of portfolio
0.05%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$64.0 - $116.06 $42,496 - $77,063
-664 Reduced 0.78%
84,114 $5.64 Million
Q2 2024

Aug 12, 2024
BUY
$110.31 - $140.45 $98,286 - $125,140
891 Added 1.06%
84,778 $9.61 Million
Q1 2024

Apr 23, 2024
SELL
$114.22 - $140.1 $1.44 Million - $1.77 Million
-12,626 Reduced 13.08%
83,887 $11.6 Million
Q4 2023

Feb 06, 2024
SELL
$75.49 - $124.16 $583,688 - $960,005
-7,732 Reduced 7.42%
96,513 $12 Million
Q3 2023

Nov 08, 2023
SELL
$86.06 - $137.93 $88,986 - $142,619
-1,034 Reduced 0.98%
104,245 $9.73 Million
Q2 2023

Aug 11, 2023
SELL
$112.47 - $130.98 $1,124 - $1,309
-10 Reduced 0.01%
105,279 $13.5 Million
Q1 2023

May 02, 2023
SELL
$104.0 - $122.92 $67,704 - $80,020
-651 Reduced 0.61%
105,289 $12.2 Million
Q4 2022

Feb 10, 2023
BUY
$84.98 - $122.67 $69,938 - $100,957
823 Added 0.78%
105,940 $12 Million
Q3 2022

Nov 09, 2022
BUY
$76.35 - $94.18 $96,124 - $118,572
1,259 Added 1.21%
105,117 $8.47 Million
Q2 2022

Aug 15, 2022
BUY
$67.99 - $132.89 $5.32 Million - $10.4 Million
78,205 Added 304.86%
103,858 $7.74 Million
Q1 2022

Jun 30, 2022
BUY
$94.08 - $130.2 $110,355 - $152,724
1,173 Added 4.79%
25,653 $13.1 Million
Q4 2021

Feb 15, 2022
BUY
$129.87 - $162.82 $380,519 - $477,062
2,930 Added 13.6%
24,480 $13.1 Million
Q3 2021

Oct 29, 2021
SELL
$106.71 - $143.18 $92,944 - $124,709
-871 Reduced 3.88%
21,550 $11.8 Million
Q2 2021

Aug 16, 2021
BUY
$80.99 - $107.93 $1.35 Million - $1.8 Million
16,719 Added 293.21%
22,421 $9.57 Million
Q1 2021

May 13, 2021
SELL
$84.79 - $104.74 $22,808 - $28,175
-269 Reduced 4.51%
5,702 $2.05 Million
Q4 2020

Feb 12, 2021
SELL
$78.0 - $104.5 $2,106 - $2,821
-27 Reduced 0.45%
5,971 $551,000
Q3 2020

Oct 30, 2020
SELL
$95.51 - $112.95 $13,084 - $15,474
-137 Reduced 2.23%
5,998 $2.47 Million
Q2 2020

Aug 10, 2020
SELL
$62.68 - $105.34 $1.11 Million - $1.87 Million
-17,751 Reduced 74.32%
6,135 $2.49 Million
Q1 2020

May 13, 2020
SELL
$47.79 - $75.63 $33,118 - $52,411
-693 Reduced 2.82%
23,886 $6.43 Million
Q4 2019

Feb 13, 2020
BUY
$36.62 - $57.29 $57,859 - $90,518
1,580 Added 6.87%
24,579 $5.38 Million
Q3 2019

Nov 13, 2019
BUY
$35.53 - $43.8 $105,488 - $130,042
2,969 Added 14.82%
22,999 $3.43 Million
Q2 2019

Aug 14, 2019
BUY
$27.84 - $38.92 $2,700 - $3,775
97 Added 0.49%
20,030 $3 Million
Q1 2019

May 15, 2019
BUY
$28.07 - $38.18 $10,133 - $13,782
361 Added 1.84%
19,933 $2.37 Million
Q4 2018

Feb 15, 2019
BUY
$26.99 - $37.37 $205,097 - $283,974
7,599 Added 63.47%
19,572 $2.35 Million
Q3 2018

Nov 14, 2018
SELL
$23.35 - $36.72 $196,863 - $309,586
-8,431 Reduced 41.32%
11,973 $1.71 Million
Q2 2018

Jul 18, 2018
BUY
$17.54 - $25.22 $36,991 - $53,188
2,109 Added 11.53%
20,404 $1.94 Million
Q1 2018

May 22, 2018
BUY
$13.06 - $18.54 $15,515 - $22,025
1,188 Added 6.94%
18,295 $1.36 Million
Q4 2017

Feb 13, 2018
BUY
$11.12 - $15.38 $10,274 - $14,211
924 Added 5.71%
17,107 $982,000
Q3 2017

Nov 09, 2017
BUY
$11.36 - $18.98 $183,838 - $307,153
16,183
16,183 $792,000

Others Institutions Holding DXCM

# of Institutions
1,013
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email